Influence of Pitavastatin Combined With Ticagrelor on Serum Monocyte Chemoattractant Protein 1 and Interleukin 10 Levels in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention
Zhang Wenya
Nanyang First People's Hospital,Nanyang 473000,China
Abstract：Objective This study was conducted to investigate the effect of pitavastatin combined with ticagrelor on serum monocyte chemoattractant protein 1（MCP-1）and interleukin 10（IL-10）levels in patients with acute myocardial infarction（AMI）after percutaneous coronary intervention（PCI）.Methods 60 patients with AMI who underwent PCI were enrolled in this study and randomly assigned to receive ticagrelor（control group,29 cases）or pitavastatin combined with ticagrelor（observation group,31 cases）.Cardiac function indexes,coagulation states before and after PCI,clinical effects and inflammatory factor levels in the 2 groups were compared.Results Before PCI,no significant differences were found between the 2 groups in left ventricular diastolic function（E/A ratio）and ejection fraction（EF）（P>0.05）.After PCI,the E/A ratio and EF increased significantly in the 2 groups,which were significantly higher in the observation group than in the control group（P<0.05）.Before PCI,no significant differences were found between the 2 groups in fibrin（Fg）and D-dimer（DD）（P>0.05）.After PCI,Fg and D-D decreased significantly in the 2 groups,which were significantly lower in the observation group than in the control group（P<0.05）.The total response rate of the observation group was 93.55%,higher than 72.41% of the control group（P>0.05）.Before PCI,no significant differences were found between the 2 groups in IL-10,MCP-1 and high-sensitivity C-reactive protein（hs-CRP）（P>0.05）.After PCI,levels of IL-10,MCP-1 and hs-CRP in the 2 groups were higher than those before operation.Additionally,the observation group had IL-10 levels but lower MCP-1 and hs-CRP levels than the control group（P<0.05）.Conclusion After PCI,using pitavastatin combined with ticagrelor in the treatment of AMI can effectively help improve cardiac function and curative effect of PCI while reducing the occurrence of inflammatory reactions,increasing IL-10 level and lowering MCP-1 level.
张文雅. 替格瑞洛与匹伐他汀联合对急性心肌梗死经皮冠状动脉介入术后患者血清单核细胞趋化蛋白1、白细胞介素10水平的影响[J]. 哈尔滨医药, 2022, 42(3): 107-108.
Zhang Wenya. Influence of Pitavastatin Combined With Ticagrelor on Serum Monocyte Chemoattractant Protein 1 and Interleukin 10 Levels in Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention. journal1, 2022, 42(3): 107-108.
2022, Vol. 42 
